Back
Beam Therapeutics, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
45
BEAM
Beam Therapeutics, Inc.
Last Price:
$27.22
Seasonality Move:
-25.3%
7 Day Trial
ALL ACCESS PASS
$
7
Beam Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Beam Therapeutics, Inc. has on average historically risen by 29% based on the past 6 years of stock performance.
-
Beam Therapeutics, Inc. has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
-
Is Beam Therapeutics, Inc. Stock Undervalued?The current Beam Therapeutics, Inc. [BEAM] share price is $28.69. The Score for BEAM is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
-
BEAM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Beam Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Beam Therapeutics, Inc. has on average historically risen by 29% based on the past 6 years of stock performance.
Beam Therapeutics, Inc. Stock Rating
Sell
45
Beam Therapeutics, Inc. (BEAM)
is a Sell
Is Beam Therapeutics, Inc. overpriced?
-
Beam Therapeutics, Inc. has risen higher in 2 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
Beam Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
beamtx.com
52-Week Data
52-Week High:
36.44
52-Week Low:
13.53
Prediction Charts
Market Cap:
2.9B
Price in USD:
28.69
Volume:
3.3M
Beta:
1.83
Technical Analysis
SMA50:
28.77
SMA100:
26.97
SMA200:
23.10
52-Wk Change:
8.92%
Stock Predictions
-
Is Beam Therapeutics, Inc. stock public?Yes, Beam Therapeutics, Inc. is a publicly traded company.
-
What is the Beam Therapeutics, Inc. stock quote today?The Beam Therapeutics, Inc. stock price is 28.69 USD today.
-
How to buy Beam Therapeutics, Inc. stock online?You can buy Beam Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-11 | 26.97 | 25.99 | 27.20 | 25.23 |
| Feb-12 | 26.09 | 26.93 | 27.02 | 25.69 |
| Feb-13 | 27.65 | 27.92 | 29.26 | 27.33 |
| Feb-17 | 27.56 | 27.49 | 28.08 | 26.20 |
| Feb-18 | 27.50 | 27.56 | 28.26 | 27.22 |
| Feb-19 | 27.42 | 27.88 | 27.91 | 26.75 |
| Feb-20 | 28.50 | 27.59 | 28.50 | 26.81 |
| Feb-23 | 27.32 | 28.33 | 28.35 | 27.06 |
| Feb-24 | 29.75 | 32.29 | 32.83 | 29.51 |
| Feb-25 | 33.00 | 29.61 | 34.20 | 29.52 |
| Feb-26 | 29.55 | 28.92 | 29.63 | 28.08 |
| Feb-27 | 28.78 | 28.46 | 28.84 | 27.57 |
| Mar-2 | 27.28 | 28.69 | 28.96 | 26.96 |
| Mar-3 | 27.17 | 27.22 | 28.29 | 26.70 |
Beam Therapeutics, Inc. Earnings
Beam Therapeutics, Inc. Earnings Report: Per Share Beam Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Beam Therapeutics, Inc. Forecast Revenue Growth
Beam Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Beam Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.05 per share, an increase next quarter of $0.26 per share, an increase this year of $0.04 per share, and a decrease next year of $0.05 per share.
* Beam Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.